Literature DB >> 15812800

A novel purification strategy for retrovirus gene therapy vectors using heparin affinity chromatography.

María de las Mercedes Segura1, Amine Kamen, Pierre Trudel, Alain Garnier.   

Abstract

Membrane separation and chromatographic technologies are regarded as an attractive alternative to conventional academic small-scale ultracentrifugation procedures used for retrovirus purification. However, despite the increasing demands for purified retroviral vector preparations, new chromatography adsorbents with high specificity for the virus have not been reported. Heparin affinity chromatography is presented here as a novel convenient tool for retrovirus purification. The ability of bioactive retroviral particles to specifically bind to heparin ligands immobilized on a chromatographic gel is shown. A purification factor of 63 with a recovery of 61% of functional retroparticles was achieved using this single step. Tentacle heparin affinity supports captured retroviral particles more efficiently than conventional heparin affinity chromatography supports with which a lower recovery was obtained (18%). Intact, infective retroviral particles were recovered by elution with low salt concentrations (350 mM NaCl). Mild conditions for retrovirus elution from chromatographic columns are required to preserve virus infectivity. VSV-G pseudotyped retroviruses have shown to be very sensitive to high ionic strength, losing 50% of their activity and showing membrane damage after a short exposure to 1M NaCl. We also report a complete scaleable downstream processing scheme for the purification of MoMLV-derived vectors that involves sequential microfiltration and ultra/diafiltration steps for virus clarification and concentration respectively, followed by fractionation by heparin affinity chromatography and final polishing by size-exclusion chromatography. Overall, by using this strategy, a 38% yield of infective particles can be achieved with a final purification factor of 2,000. (c) 2005 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15812800     DOI: 10.1002/bit.20301

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  16 in total

1.  Entry kinetics and cell-cell transmission of surface-bound retroviral vector particles.

Authors:  Lee S O'Neill; Amy M Skinner; Josha A Woodward; Peter Kurre
Journal:  J Gene Med       Date:  2010-05       Impact factor: 4.565

2.  Selection of novel vesicular stomatitis virus glycoprotein variants from a peptide insertion library for enhanced purification of retroviral and lentiviral vectors.

Authors:  Julie H Yu; David V Schaffer
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

3.  An all-feline retroviral packaging system for transduction of human cells.

Authors:  Raymond T Doty; Kathleen M Sabo; Jing Chen; A Dusty Miller; Janis L Abkowitz
Journal:  Hum Gene Ther       Date:  2010-08       Impact factor: 5.695

4.  Identification of host proteins associated with retroviral vector particles by proteomic analysis of highly purified vector preparations.

Authors:  María Mercedes Segura; Alain Garnier; Marcos Rafael Di Falco; Gavin Whissell; Angélica Meneses-Acosta; Normand Arcand; Amine Kamen
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

5.  Scale-up and manufacturing of clinical-grade self-inactivating γ-retroviral vectors by transient transfection.

Authors:  J C M van der Loo; W P Swaney; E Grassman; A Terwilliger; T Higashimoto; A Schambach; C Baum; A J Thrasher; D A Williams; D L Nordling; L Reeves; P Malik
Journal:  Gene Ther       Date:  2011-07-14       Impact factor: 5.250

6.  Highly efficient concentration of lenti- and retroviral vector preparations by membrane adsorbers and ultrafiltration.

Authors:  Katrin Zimmermann; Oliver Scheibe; Andreas Kocourek; Jutta Muelich; Elke Jurkiewicz; Alexander Pfeifer
Journal:  BMC Biotechnol       Date:  2011-05-20       Impact factor: 2.563

7.  Optimised concentration and purification of retroviruses using membrane chromatography.

Authors:  D J McNally; D Darling; F Farzaneh; P R Levison; N K H Slater
Journal:  J Chromatogr A       Date:  2014-03-15       Impact factor: 4.759

8.  Production and purification of high-titer foamy virus vector for the treatment of leukocyte adhesion deficiency.

Authors:  Md Nasimuzzaman; Danielle Lynn; Rebecca Ernst; Michele Beuerlein; Richard H Smith; Archana Shrestha; Scott Cross; Kevin Link; Carolyn Lutzko; Diana Nordling; David W Russell; Andre Larochelle; Punam Malik; Johannes C M Van der Loo
Journal:  Mol Ther Methods Clin Dev       Date:  2016-03-16       Impact factor: 6.698

9.  De Novo Isolation & Affinity Maturation of yeast-displayed Virion-binding human fibronectin domains by flow cytometric screening against Virions.

Authors:  Pete Heinzelman; Alyssa Low; Rudo Simeon; Gus A Wright; Zhilei Chen
Journal:  J Biol Eng       Date:  2019-10-16       Impact factor: 4.355

10.  Downstream Processing: From Egg to Cell Culture-Derived Influenza Virus Particles.

Authors:  M W Wolff; U Reichl
Journal:  Chem Eng Technol       Date:  2008-05-27       Impact factor: 1.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.